Wonbiogen Co.,Ltd.
Wonbiogen Co.,Ltd., established September 2018, listed on KOSDAQ in December 2018, manufactures wound dressings and moist wound dressings.
As of 2026-10-10, Wonbiogen Co.,Ltd. has 66 Korean MFDS device approvals, 3 PubMed-indexed papers on record (counted by the MAA Company Index from its own matching of public databases).
Price
Change
Market cap
Business overview
Source: DART corporate disclosureWonbiogen Co.,Ltd. was established on September 3, 2018 and listed on the KOSDAQ market on December 5, 2018 as a medical device company. It manufactures wound dressings and moist wound dressings. It operates in the domestic wound dressing market alongside companies such as Smith & Nephew, Molnlycke, Coloplast, Convatec, and Genewell.
Products & technology
- wound dressing
- moist wound dressing
Regulatory approvals
data.go.kr66 Korean MFDS device approvals · 2015–2026
- MFDSDressing, high-absorbent, foam/sheet/liquid/powder2026-06-19Product approval · Class 2제인 26-4546 호
- MFDSDressing, high-absorbent, foam/sheet/liquid/powder2026-06-19Product approval · Class 2제인 26-4545 호
- MFDSDressing, high-absorbent, foam/sheet/liquid/powder2026-06-19Product approval · Class 2제인 26-4544 호
- MFDSDressing, secondardy treatment, high-absorbent, foam/ sheet/ liquid/powder2026-06-12Product approval · Class 3제허 26-444 호
- MFDSDressing, secondardy treatment, high-absorbent, foam/ sheet/ liquid/powder2026-06-12Product approval · Class 3제허 26-443 호
- MFDSDressing, secondardy treatment, high-absorbent, foam/ sheet/ liquid/powder2026-06-12Product approval · Class 3제허 26-442 호
- MFDSDressing, high-absorbent, foam/sheet/liquid/powder2026-02-04Product approval · Class 2제인 26-4113 호
- MFDSDressing, secondardy treatment, high-absorbent, foam/ sheet/ liquid/powder2025-03-31Product approval · Class 3제허 25-205 호
- MFDSDressing, secondardy treatment, high-absorbent, foam/ sheet/ liquid/powder2025-03-31Product approval · Class 3제허 25-204 호
- MFDSDressing, occlusive, hydrogel2025-01-21Product approval · Class 2제인 25-4077 호
- MFDSDressing, high-absorbent, foam/sheet/liquid/powder2024-01-31Product approval · Class 2제허 24-79 호
- MFDSDressing, high-absorbent, foam/sheet/liquid/powder2023-05-09Product approval · Class 2제인 23-4703 호
Show 54 more
- MFDSDressing, high-absorbent, foam/sheet/liquid/powder2023-02-28Product approval · Class 2제인 23-4214 호
- MFDSDressing, secondardy treatment, high-absorbent, foam/ sheet/ liquid/powder2023-02-22Product approval · Class 3제허 23-126 호
- MFDSDressing, occlusive, hydrogel2023-02-10Product approval · Class 2제인 23-4145 호
- MFDSDressing, occlusive, hydrogel2023-01-11Product approval · Class 2제인 23-4054 호
- MFDSDressing, secondardy treatment, high-absorbent, foam/ sheet/ liquid/powder2022-10-27Product approval · Class 3제허 22-724 호
- MFDSDressing, secondardy treatment, high-absorbent, foam/ sheet/ liquid/powder2022-10-21Product approval · Class 3제허 22-713 호
- MFDSDressing, fluid-impermeable film2022-10-07Product approval · Class 2제인 22-4761 호
- MFDSDressing, fluid-impermeable film2022-09-20Product approval · Class 2제인 22-4692 호
- MFDSDressing, fluid-impermeable film2022-09-01Product approval · Class 2제인 22-4637 호
- MFDSDressing, fluid-impermeable film2022-08-24Product approval · Class 2제인 22-4622 호
- MFDSDressing, fluid-impermeable film2022-08-24Product approval · Class 2제인 22-4621 호
- MFDSDressing, occlusive, hydrogel2022-08-24Product approval · Class 2제인 22-4620 호
- MFDSDressing, occlusive, hydrogel2022-08-12Product approval · Class 2제인 22-4594 호
- MFDSSuction system, low pressure2022-07-26Product approval · Class 2제인 22-4558 호
- MFDSDressing, occlusive, hydrogel2022-04-26Product approval · Class 2제인 22-4328 호
- MFDSDressing, secondardy treatment, high-absorbent, foam/ sheet/ liquid/powder2022-04-18Product approval · Class 3제허 22-254 호
- MFDSSurgical supplies2022-03-30Product approval · Class 1제신 22-409 호
- MFDSBandage, compressionRevoked2022-03-03Product approval · Class 1제신 22-292 호
- MFDSPad, skin, protective2022-02-17Product approval · Class 1제신 22-215 호
- MFDSDressing, occlusive, hydrogel2022-01-04Product approval · Class 2제인 22-4002 호
- MFDSDressing, occlusive, hydrogel2021-12-13Product approval · Class 2제인 21-5030 호
- MFDSDressing, fluid-impermeable film2021-10-22Product approval · Class 2제인 21-4898 호
- MFDSDressing, fluid-impermeable film2021-07-01Product approval · Class 2제인 21-4565 호
- MFDSDressing, fluid-impermeable film2021-06-22Product approval · Class 2제인 21-4534 호
- MFDSDressing, secondardy treatment, high-absorbent, foam/ sheet/ liquid/powder2021-05-28Product approval · Class 3제허 21-428 호
- MFDSThermometer, electronic2021-05-11Product approval · Class 2제인 21-4402 호
- MFDSDressing, fluid-impermeable film2021-04-19Product approval · Class 2제인 21-4315 호
- MFDSDressing, fluid-impermeable film2021-01-20Product approval · Class 2제인 21-4040 호
- MFDSDressing, fluid-impermeable film2021-01-19Product approval · Class 2제허 21-45 호
- MFDSDressing, fluid-impermeable film2020-11-05Product approval · Class 2제인 20-4988 호
- MFDSDressing, fluid-impermeable film2020-10-20Product approval · Class 2제인 20-4946 호
- MFDSDressing, fluid-impermeable film2020-05-19Product approval · Class 2제인 20-4395 호
- MFDSDressing, occlusive, hydrogel2019-10-08Product approval · Class 2제인 19-4832 호
- MFDSDressing, secondary treatment, occlusive, hydrogel2018-12-11Product approval · Class 3제허 18-788 호
- MFDSDressing, fluid-impermeable film2018-11-16Product approval · Class 2제인 18-4940 호
- MFDSDrape Adhesive, AerosolRevoked2018-08-10Product approval · Class 1제신 18-1029 호
- MFDSDrape Adhesive, AerosolRevoked2018-08-10Product approval · Class 1제신 18-1028 호
- MFDSDressing, secondardy treatment, high-absorbent, foam/ sheet/ liquid/powder2018-07-02Product approval · Class 3제허 18-468 호
- MFDSDressing, secondardy treatment, high-absorbent, foam/ sheet/ liquid/powder2018-06-27Product approval · Class 3제허 18-460 호
- MFDSDressing, secondardy treatment, high-absorbent, foam/ sheet/ liquid/powder2018-06-26Product approval · Class 3제허 18-452 호
- MFDSDressing, secondardy treatment, high-absorbent, foam/ sheet/ liquid/powder2018-06-25Product approval · Class 3제허 18-451 호
- MFDSDressing, secondardy treatment, high-absorbent, foam/ sheet/ liquid/powder2018-06-25Product approval · Class 3제허 18-450 호
- MFDSDressing, secondardy treatment, high-absorbent, foam/ sheet/ liquid/powder2018-06-22Product approval · Class 3제허 18-447 호
- MFDSDressing, secondardy treatment, high-absorbent, foam/ sheet/ liquid/powder2018-06-19Product approval · Class 3제허 18-432 호
- MFDSDressing, secondary treatment, occlusive, hydrogel2018-06-14Product approval · Class 3제허 18-411 호
- MFDSDressing, secondardy treatment, high-absorbent, foam/ sheet/ liquid/powder2018-03-08Product approval · Class 3제허 18-159 호
- MFDSDressing, secondardy treatment, high-absorbent, foam/ sheet/ liquid/powder2018-03-08Product approval · Class 3제허 18-158 호
- MFDSDressing, occlusive, hydrogel2017-12-08Product approval · Class 2제인 17-4945 호
- MFDSDressing, secondardy treatment, high-absorbent, foam/ sheet/ liquid/powder2016-07-25Product approval · Class 3제허 16-553 호
- MFDSDressing, fluid-impermeable film2016-06-17Product approval · Class 2제인 16-4510 호
- MFDSDressing, fluid-impermeable film2016-06-07Product approval · Class 2제인 16-4467 호
- MFDSDressing, secondary treatment, occlusive, hydrogel2016-02-16Product approval · Class 3제허 16-111 호
- MFDSDressing, secondary treatment, occlusive, hydrogel2015-12-04Product approval · Class 3제허 15-1648 호
- MFDSDressing, fluid-impermeable film2015-05-29Product approval · Class 2제인 15-819 호
Key disclosures
KRX KIND via OpenDARTPublications
PubMed · affiliation-matched- Preventing postoperative tissue adhesion using injectable carboxymethyl cellulose-pullulan hydrogels.
International journal of biological macromolecules · 2017-12 · Bang S, Ko YG, Kim WI 외 3
- Nanofiber mats composed of a chitosan-poly(d,l-lactic-co-glycolic acid)-poly(ethylene oxide) blend as a postoperative anti-adhesion agent.
Journal of biomedical materials research. Part B, Applied biomaterials · 2017-10 · Ko JE, Ko YG, Kim WI 외 2
- Injectable pullulan hydrogel for the prevention of postoperative tissue adhesion.
International journal of biological macromolecules · 2016-06 · Bang S, Lee E, Ko YG 외 2
Patents
KIPRIS · applicant-matchedPublished · 2026-03 · Application 1020260055898
Registered · 2024-08 · Application 1020240105161
Registered · 2024-06 · Application 1020240076756
Registered · 2023-01 · Application 1020230008917
Rejected · 2021-01 · Application 1020210011872
PCT · Published · 2020-12 · Application PCT/KR2020/018159
Registered · 2020-11 · Application 1020200147542
Registered · 2020-03 · Application 1020200037241
Registered · 2020-02 · Application 1020200021218
Registered · 2018-07 · Application 1020180088663
Show 8 more patents
Registered · 2017-07 · Application 1020170093999
CN · Published · 2015-10 · Application 201510729403.4
CN · Published · 2014-06 · Application 201410270368
CN · Published · 2014-06 · Application 201410265857
PCT · Published · 2012-08 · Application PCT/KR2012/006536
CN · Published · 2008-06 · Application 200880021100
PCT · Published · 2008-06 · Application PCT/KR2008/003414
PCT · Published · 2007-04 · Application PCT/KR2007/002078
AI reads
MAA server logs · IP-verifiedPulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.
Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.
Collected as raw material for future answers.
Queries from users who connected this index to their own AI.
- OpenAIChatGPT-Userlive1
- OpenAIOAI-SearchBot92
- GoogleGoogleOther12
- PerplexityPerplexityBot3
- AnthropicClaudeBot2
- MicrosoftBingbot1
Measured since Aug 27, 2026 · 5 AI engines · last read Oct 8, 2026
User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.
Connect this company index directly to your AI
Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for Wonbiogen Co.,Ltd. and every listed Korean medical, bio and AI company.
How to connect (MCP)Companies approved for the same productsMedical Devices
Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.
KOSDAQ-listed comprehensive healthcare and pharmaceutical company behind the gum treatment Insadol and the wound-care ointment Madecassol.
KOSDAQ-listed medical device company producing human tissue implants Bella Cell HD and SureFuse.
Founded in 2013 and KOSDAQ-listed in 2018, T&R Biofab commercializes 3D bioprinting systems, bioinks, and biodegradable scaffolds.
KOSDAQ-listed medical device company producing PDRN pharmaceuticals, HA fillers, and Rejuran-branded cosmetics.
Founded and listed on the KOSDAQ in 2016, BNC Korea is a biohealthcare company specializing in HA fillers, botulinum toxin, and dermo-cosmetics.
Founded in 1945, JW Pharmaceutical holds an original drug pipeline including Rivalo and Hemlibra, plus the IV nutrition product Winuf and OTC brand Hwakol.
KOSPI-listed operating holding company of the Hanmi Pharm group, also running healthcare and pharmaceutical wholesale businesses.
Founded in 1982 and KOSDAQ-listed in 2008, Sewoon Medical manufactures medical aspirators and catheters/tubes.
KOSDAQ-listed aesthetics and CMO company behind the Elravie/Revolax hyaluronic-acid fillers and Leedstox botulinum toxin.
Established in 1998 and listed on KOSDAQ in 2020, T&L manufactures wound dressings, microneedles, and orthopedic fixation products.
Founded and listed on the KOSPI in 2016, Il Dong Pharmaceutical manufactures products including the Aronamin vitamin line.
Dong-A ST, spun off from Dong-A Socio Holdings in 2013 and KOSPI-listed, makes prescription drugs like Growtropin, Stillen, and Bacchus.
Sources and updates
Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- Approvals & clinical trials
- Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
- Key disclosures
- KRX KIND via OpenDART exchange filings — updated daily
- Global clinical trials
- ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
- Financials
- DART corporate disclosure filings — annual
- Publications
- PubMed (US National Library of Medicine) — affiliation-matched, updated daily
- Patents
- KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
- AI reads
- Our server logs, IP-verified every 6 hours
- AI visibility
- Measured 2026-10-01
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition